Kristen Sheppard Net Worth

Insiders trading at Akebia Therapeutics

Over the last 10 years, insiders at Akebia Therapeutics have traded over $2,966,304 worth of Akebia Therapeutics stock and bought 2,141,907 units worth $27,915,834 . The most active insiders traders include Holdings A/S Novo, Muneer A Satter, and Mark J Enyedy. On average, Akebia Therapeutics executives and independent directors trade stock every 28 days with the average trade being worth of $51,921. The most recent stock trade was executed by Michel Dahan on 29 February 2024, trading 8,661 units of AKBA stock currently worth $13,684.